Here Is What Valeda Can Do for Your Dry AMD Patients
By: Tyler Q. Kirk, MD VOLUME 1 | ISSUE 3 Valeda® Light Therapy is the first FDA-authorized photobiomodulation (PBM) treatment for Dry Age-Related Macular Degeneration (AMD). Using red, yellow, and near-infrared light to stimulate retinal cells, enhances mitochondrial function, promotes cellular repair, and slows disease progression. In the landmark LightSite III trial, patients with moderate…
Read More
Why We Chose the Catalys Laser
By: Tyler Q. Kirk, MD VOLUME 1 | ISSUE 2 Femtosecond Laser -Assisted Cataract Surgery (FLACS) Experience: Reasons to Recommend Who is not a good FLACS candidate?-Prior RK-incomplete capsulotomy-Prior filtering bleb-although liquid interface is gentle, we avoid disrupting thin walled cystic blebs.-Poor dilatation or posterior synechia- unable to have adequate penetrance and capsulotomy-Anterior chamber cell,…
Read More
Your Patients Deserve Interventional Glaucoma
By: Tyler Q. Kirk, MD VOLUME 1 | ISSUE 1 For over a decade, Kirk Eye Center has viewed selective laser trabeculoplasty (SLT) as a first-line option for newly diagnosed glaucoma management. We immediately recognized its benefits over topical drop therapy; continuous action, no dependence on compliance, no serious long term side effects, repeatability, and…
Read More
